A Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients With Moderate to Severe Hidradenitis Suppurativa
Public ClinicalTrials.gov record NCT06603077. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients With Moderate to Severe Hidradenitis Suppurativa (LOTUS)
Study identification
- NCT ID
- NCT06603077
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Avalo Therapeutics, Inc.
- Industry
- Enrollment
- 253 participants
Conditions and interventions
Conditions
Interventions
- AVTX-009 Regimen 1 Drug
- AVTX-009 Regimen 2 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 15, 2024
- Primary completion
- Feb 22, 2026
- Completion
- Mar 16, 2026
- Last update posted
- Apr 20, 2026
2024 – 2026
United States locations
- U.S. sites
- 36
- U.S. states
- 17
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Site 1022 | Scottsdale | Arizona | 85260 | — |
| Clinical Site 1037 | Scottsdale | Arizona | 85260 | — |
| Clinical Site 1026 | Tucson | Arizona | 85704 | — |
| Clinical Site 1032 | Northridge | California | 91325 | — |
| Clinical Site 1019 | Pomona | California | 91767 | — |
| Clinical Site 1009 | Sacramento | California | 95815 | — |
| Clinical Site 1034 | Santa Monica | California | 90024 | — |
| Clinical Site 1011 | Washington D.C. | District of Columbia | 20010 | — |
| Clinical Site 1029 | Boca Raton | Florida | 33486 | — |
| Clinical Site 1002 | Coral Gables | Florida | 33134 | — |
| Clinical Site 1015 | Maitland | Florida | 32751 | — |
| Clinical Site 1027 | North Miami Beach | Florida | 33162-4708 | — |
| Clinical Site 1013 | Tampa | Florida | 33613 | — |
| Clinical Site 1008 | Savannah | Georgia | 31419 | — |
| Clinical Site 1014 | Chicago | Illinois | 60640 | — |
| Clinical Site 1028 | West Lafayette | Indiana | 47906 | — |
| Clinical Site 1031 | Bowling Green | Kentucky | 42104 | — |
| Clinical Site 1024 | Murray | Kentucky | 42071 | — |
| Clinical Site 1042 | Boston | Massachusetts | 02115-5804 | — |
| Clinical Site 1001 | Boston | Massachusetts | 02215 | — |
| Clinical Site 1030 | Detroit | Michigan | 48201 | — |
| Clinical Site 1007 | Fort Gratiot | Michigan | 48059 | — |
| Clinical Site 1041 | Oakland | Michigan | 48328 | — |
| Clinical Site 1003 | Portsmouth | New Hampshire | 03801 | — |
| Clinical Site 1036 | Brooklyn | New York | 10023 | — |
| Clinical Site 1016 | New York | New York | 10003 | — |
| Clinical Site 1023 | The Bronx | New York | 10467 | — |
| Clinical Site 1020 | Cincinnati | Ohio | 45219 | — |
| Clinical Site 1010 | Cleveland | Ohio | 44106 | — |
| Clinical Site 1017 | Dublin | Ohio | 43016 | — |
| Clinical Site 1004 | Philadelphia | Pennsylvania | 19103 | — |
| Clinical Site 1035 | Pittsburgh | Pennsylvania | 15213 | — |
| Clinical Site 1018 | Johnston | Rhode Island | 02919 | — |
| Clinical Site 1025 | Providence | Rhode Island | 02903 | — |
| Clinical Site 1005 | Greenville | South Carolina | 29615 | — |
| Clinical Site 1012 | Arlington | Texas | 76011 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 53 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06603077, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 20, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06603077 live on ClinicalTrials.gov.